Celcuity Secures Landmark FDA Approval for Breast Cancer Drug Revtorpyk Amidst Investor Concerns Over Launch Delay and Prescribing Information
Celcuity, a burgeoning player in the biopharmaceutical sector, marked a pivotal milestone on Tuesday, July...
